期刊文献+

hCaMKⅡNα对结肠肿瘤分泌免疫抑制因子的抑制作用

The inhibitory effect of hCaMKⅡNα on the production of immunosuppressive factors in colon cancer cells in vitro
下载PDF
导出
摘要 目的:探讨钙离子/钙调素依赖性蛋白激酶Ⅱ抑制蛋白α(human calcium/calmodulin-dependent protein kinaseⅡinhibitory alpha,hCaMKⅡNα)对结肠肿瘤细胞分泌免疫抑制因子的影响及其作用机制。方法:将hCaMKⅡNα基因表达载体(pKⅡNα)或siRNA(si-KⅡNα)转染至结肠肿瘤细胞(LoVo细胞、SW620细胞和HT29细胞),形成过表达或干扰表达细胞。RT-PCR检测结肠癌LoVo细胞过表达hCaMKⅡα后白细胞介素-8(interleukin-8,IL-8)、白细胞介素-10(interleukin-10,IL-10)和血管内皮生长因子(vascular endothelial cell growth factor,VEGF)mRNA表达水平,ELISA法检测转染pKⅡNα或si-KⅡNα对SW620和LoVo细胞中VEGF、PGE2、IL-8和IL-10分泌的影响。为观测细胞外调节蛋白激酶1/2(extracellular regulated protein kinases,ERK1/2)在hCaMKⅡNα介导的细胞因子调控中的作用,利用U0126抑制HT-29细胞中ERK1/2活性后,检测hCaMKⅡNα表达下调对VEGF和IL-8分泌的影响。结果:hCaMKⅡ可显著抑制结肠癌LoVo细胞中VEGF、IL-8和IL-10mRNA水平的表达;可抑制SW620和LoVo细胞中IL-8和VEGF蛋白的分泌,但对PGE2和IL-10的分泌没有影响。相应地,利用RNA干扰技术下调hCaMKⅡNα表达可显著上调HT29细胞中IL-8和VEGF的分泌;并且发现MEK1/2活性的抑制可完全阻断hCaMKⅡNα对IL-8的影响,但只能部分阻断对VEGF的影响。结论:hCaMKⅡNα通过抑制ERK活性下调结肠肿瘤细胞VEGF和IL-8的分泌,在结肠肿瘤免疫逃逸中起到负相调控作用。 Objective: To investigate the effect of( human calcium/calmodulin-dependent protein kinase Ⅱ inhibitory alpha( hCaMKⅡN-α) on the production of immunosuppressive factors in colon cancer cells and the mechanisms underlying the effect in vitro. Methods: Overexpression and silencing of the hCaMKⅡN-α gene in human colon adenocarcinoma( LoVo,SW620 and HT29) cells were achieved by transfection with a hCaMKⅡN-α-expressing plasmid( pKⅡN-α) and an siRNA( si-KⅡN-α) vector,respectively. Messenger RNA levels of interleukin-8( IL-8),interleukin-10( IL-10) and vascular endothelial cell growth factor( VEGF) in LoVo cells transfected with pKⅡN- were analyzed by RT-PCR. Protein levels of IL-8,IL-10 and VEGF in SW620 and LoVo cells transfected with pKⅡN- and in HT29 cells transfected with si-KⅡN-were determined by ELISA. The differences in IL-8 and VEGF protein levels in HT29 cells transfected with pKIN-α in the presence or absence of U0126( 10 M),a selective ERK1 /2 inhibitor,were analyzed to elucidate the role of ERK1 /2 in hCaMKⅡN-α-mediated IL-8 and VEGF production. Results: Overexpression of hCaMKⅡN- significantly decreased the mRNA abundance and protein levels of VEGF and IL-8( P 〈 0. 05) but not PGE2( P 〉 0. 01). Silencing of hCaMKⅡN-by siRNA significantly increased the secretion of VEGF and IL-8 in HT29 cells,but had no effect on the secretion of PGE2 and IL-10. U0126 treatment resulted in a complete reversion of increased IL-8 secretion but only a partial reversion of increased VEGF secretion in HT29 cells overexpressing hCaMKⅡ-α. Conclusion: Our observations suggest that hCaMKⅡ- may inhibit the secretion of VEGF and IL-8 and thus down-regulate the immune response in rectal tumor cells through an ERK signaling pathway-dependent mechanism.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2014年第3期263-268,共6页 Chinese Journal of Cancer Biotherapy
基金 国家自然科学基金资助项目(No.31270931)~~
关键词 钙离子 钙调素依赖性蛋白激酶Ⅱ抑制蛋白 结肠肿瘤 LOVO细胞 SW620细胞 HT29细胞 VEGF IL-8 IL-10 human calcium/calmodulin-dependent protein kinaseⅡ inhibitory alpha(hCaMKⅡNα) colon carcinoma LoVo cell SW620 cell H29 cell VEGF IL-8 IL-10
  • 相关文献

参考文献20

  • 1Mockett BG, Cuevremont 0, Wutte M, et al. Calcium/calmodulin-dependent protein kinase II mediates group I metabotropic glutamate receptor-dependent protein synthesis and long-term depression in rat hippocampus [J]. J Neurosci , 20 II , 3] ( 20) : 7380- 7391.
  • 2Chang BH, Mukherji S, Soderling TR. Alcium/ calmodulin-de- pendent protein kinase II inhibitor protein: Localization of isoforms in rat brain [J]. Neuroscience, 2001,102(4): 767-777.
  • 3Wang C, Li N, Liu X, et al. A novel endogenous human CaMK II inhibitory protein suppressestumor growth by inducing cell cycle arrest via p27 stabilization [J]. J Bioi Chern, 2008, 283 ( 17 ) : 11565-11574.
  • 4Erickson JR, Pereira L, Wang L, et al. Diabetic hyperglycaemia activates CaMK II and arrhythmias by O-linked glycosylation [J]. UOl26 Nature, 2013,502(7471): 372-376.
  • 5Koon HW, Zhao 0, Zhan Y, et al. Substance P-stimulated inter- leukin-8 expression in human colonic epithelial cells involves pro- tein kinase Cdelta activation [J]. J Pharmacol Exp Ther, 2005, 314(3): 1393-1400.
  • 6Ahluwalia A, Jones MK, Szabo S, et al. Aberrant, ectopic expression of VEGF and VEGF receptors I and 2 in malignant colonic epithelial cells. Implications for these cells growth via a autocrine mechanism [J]. Biochem Biophys Res Commun, 2013, 437 (4) : 515-520.
  • 7Eisinger AL, Prescott SM, Jones DA, et al. The role of cyclooxygenase-2 and prostaglandins in colon cancer [J]. Prostaglandins Other Lipid Mediat, 2007, 82( 114): 147-154.
  • 8Sato Y, Takahashi S, Kinouchi Y, et al. IL-IO deficiency leads to somatic mutations in a model of IBO [J]. Carcinogenesis, 2006, 27(5): 1068-1073.
  • 9Tougeron 0, Fauquembergue E, Latouche JB. Immune response and colorectal cancer [J]. Bull Cancer, 2013, 100 ( 3 ): 283- 294.
  • 10Giatromanolaki A, Sivridis E, Koukourakis Ml. Angiogenesis in colorectal cancer: Prognostic and therapeutic implications [J] . Am J Clin Oncol, 2006, 29 (4) : 408-417.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部